Cat.#: ACPP-1331
| Despition | GPR56 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1691 | Human MGLL Protein (AC1691) | 2 µg | inquiry |
| ACPP-1779 | Human HSD17B10 Protein (AC1779) | 5 µg | inquiry |
| ACPP-1082 | Human CACYBP Protein (AC1082) | 5 µg | inquiry |
| ACPP-1181 | Synthetic Nanodisc Human CX3CR1 Protein (AC1181) | 10 µg | inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
| ACPP-1788 | Human NEUROG3 Protein (AC1788) | 2 µg | inquiry |
| ACPP-1703 | Human PITPNA Protein (AC1703) | 5 µg | inquiry |
| ACPP-1274 | Visfatin Blocking Peptide (AC1274) | 250 µg | inquiry |
| ACPP-1638 | Human CNTF Protein (AC1638) | 5 µg | inquiry |
| ACPP-1541 | Human OTOR Protein (AC1541) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.